TheBanker

$IMMU

Short
NASDAQ:IMMU   None
After a nice deal with SGEN last week the EV is 400m this is likely as high as it will ever get. Awful pipeline with sacituzumab (an archaic chemotherapy style) we should see this move back to sub 3 in the near term before a further push to 2.30.

Time will tell!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.